论文部分内容阅读
目的:本文主要是对卡维地洛治疗心肌梗死后左心功能不全的临床效果进行分析与研究。方法:选取我院在2014年6月-2016年7月收治的72例心肌梗死后左心功能不全患者,采用随机方式将这72例患者分为参照组与研究组各36例,参照组患者进行常规治疗,研究组患者在参照组治疗基础上再使用卡维地洛进行治疗,对两组患者的临床治疗效果进行统计与比较。结果:参照组患者取得的临床治疗总有效率为69.44%,研究组患者取得的临床治疗总有效率为94.44%,研究组患者的治疗总有效率显著高于参照组,取得的治疗效果更加显著,P<0.05。结论:对心肌梗死后左心功能不全患者使用卡维地洛进行治疗可以取得良好的临床疗效,降低了患者的死亡率,保证了患者的生命安全,值得在今后的临床工作中加以大力推广与运用。
Objective: This article mainly analyzes and studies the clinical effect of carvedilol on left ventricular dysfunction after myocardial infarction. Methods: Seventy-two patients with left ventricular dysfunction after myocardial infarction in our hospital from June 2014 to July 2016 were randomly divided into the reference group and the study group, with 36 cases in each group. The patients in the reference group The patients in the study group were treated with carvedilol on the basis of the reference group, and the clinical effects of the two groups were statistically compared. Results: The total effective rate of clinical treatment in the reference group was 69.44%. The total effective rate of clinical treatment in the study group was 94.44%. The total effective rate of the study group was significantly higher than that of the reference group and the treatment effect was more significant , P <0.05. Conclusion: The treatment of carvedilol in patients with left ventricular dysfunction after myocardial infarction can achieve good clinical efficacy, reduce the mortality of patients and ensure the patient’s life safety, which is worth to be promoted in future clinical work. use.